Why BioCryst Pharmaceuticals Stock Is Popping Today

Why BioCryst Pharmaceuticals Stock Is Popping Today

Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) are trading higher on Wednesday following the company's announcement of positive news regarding its hereditary angioedema (HAE) treatment, Orladeyo. The company's stock was up by 6.2% as of 3:33 p.m. EDT, after rising by as much as 9.8% earlier in the trading session. Back in January, oral once-daily Orladeyo was approved in Japan for prophylactic treatment of HAE.